Shailender Bhatia, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    4SC
    Topic:
    Research funding
    Date added:
    03/09/2023
    Date updated:
    02/13/2024
    Relationship end date:
    03/10/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Agenus
    Topic:
    Research funding
    Date added:
    03/09/2023
    Date updated:
    02/13/2024
    Relationship end date:
    03/10/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Amphivena
    Topic:
    Research funding
    Date added:
    03/09/2023
    Date updated:
    02/13/2024
    Relationship end date:
    03/11/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Bristol Meyers Squibb
    Topic:
    Research funding
    Date added:
    03/09/2023
    Date updated:
    02/13/2024
    Relationship end date:
    03/10/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Regeneron (fka Checkmate Pharmaceuticals)
    Topic:
    Research funding
    Date added:
    03/09/2023
    Date updated:
    02/13/2024
    Relationship end date:
    03/10/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    EMD Serono
    Topic:
    Research funding
    Date added:
    03/09/2023
    Date updated:
    02/13/2024
    Relationship end date:
    03/10/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Exicure
    Topic:
    Research funding
    Date added:
    03/09/2023
    Date updated:
    02/13/2024
    Relationship end date:
    12/31/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Incyte
    Topic:
    Research funding
    Date added:
    03/09/2023
    Date updated:
    02/13/2024
    Relationship end date:
    03/10/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Kuni Foundation
    Topic:
    Research funding
    Date added:
    03/09/2023
    Date updated:
    02/13/2024
    Relationship end date:
    03/10/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck
    Topic:
    Research funding
    Date added:
    03/09/2023
    Date updated:
    02/13/2024
    Relationship end date:
    03/10/2025

Pages

Return to 4th Binaytara Precision Oncology Summit: Current Standards and Emerging Therapies